Condition: Confirmed Diagnosis of Cystic Fibrosis · Sponsor: Insel Gruppe AG, University Hospital Bern
This study collects data on microbiological factors and lung function parameters (e.g. spirometry, body plethysmography, lung-MRI) to assess their interaction on the lung growth and lung development of infants and children with Cystic Fibrosis (CF).
This description comes directly from the study's public registry record.
Philipp Latzin, MD PhD · 0041 31 632 94 93 · philipp.latzin@insel.ch
Always discuss trial participation with your own doctor first.
| University Children's Hospital Bern | Bern, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04026360